09.23.11
Procter & Gamble has signed a deal with Intralytix Inc. to collaborate on the development of new products using antibacterial technology, according to a statement from Intralytix.
Baltimore, Md.-based Intralytix is a biotechnology company that already has two bacteriophage-based products on the market that reduce or eliminate harmful bacteria. A bacteriophage is a virus that infects bacteria. Bacteriophage therapy is commonly used as an alternative to antibiotics in parts of Eastern Europe.
Intralytix's technology has applications in sanitation, food safety, veterinary products and human therapeutics.
More info: www.intralytix.com
Intralytix's technology has applications in sanitation, food safety, veterinary products and human therapeutics.
More info: www.intralytix.com